IP Library Granted Patent US 9,186,385
Granted Patent B2
US 9,186,385 · App. 12/716,167 · Granted Nov 17, 2015

Plant extract compositions for prevention and treatment of influenza

Inventors: Xueju Xie (Richmond, CA); Jason Jiang-Chung Ko (Richmond, CA)
Assignee: Viva Pharmaceutical Inc.
A61K36/076A61K36/185A61K36/315A61K36/355
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,186,385
App. No.
12/716,167
Granted
Nov 17, 2015
Kind
B2
Abstract

A composition for affecting one or more of influenza, inflammation, and immune system function, said composition comprising an extract prepared from Radix isatidis and an extract prepared from Flos Lonicerae . In alternative embodiments, the composition further comprises one or more of an extract prepared from Poria cocos (Schw.) Wolf and an extract prepared from Herba houttuyniae . Method for treating one or more of influenza, inflammation by administering a patient a therapeutically effective amount of the above composition.

Claims (30)

1. A composition consisting of:

a therapeutically effective amount of an extract consisting of individual extracts of Radix isatidis, Flos Lonicerae , and Poria cocos (Schw.) Wolf; for the treatment of influenza; and

at least one of a pharmaceutically acceptable carrier and an excipient, wherein the individual extracts of Radix isatidis, Lonicera japonicum and Poria cocos F. A. Wolf are present in a ratio of about 1.0:1.0:2.1.

2. A composition according to claim 1 , wherein said composition is an oral dosage form.

3. A composition according to claim 2 , wherein said oral dosage form is selected from the group consisting of tablets, pills, softgel capsules, hard capsules, granules, powders, concentrates, syrups, liquids, molded balls and combinations thereof.

4. A composition consisting of:

a therapeutically effective amount of an extract consisting of individual extracts of Radix isatidis, Flos Lonicerae , and Poria cocos (Schw.) Wolf, for the treatment of respiratory inflammation; and

at least one of a pharmaceutically acceptable carrier and an excipient, wherein the individual extracts of Radix isatidis, Lonicera japonicum and Poria cocos F. A. Wolf are present in a ratio of about 1.0:1.0:2.1.

5. A composition according to claim 4 , wherein said composition is an oral dosage form.

6. A composition according to claim 4 , wherein said composition is an oral dosage form, and wherein said oral dosage form is selected from the group consisting of tablets, pills, softgel capsules, hard capsules, granules, powders, concentrates, syrups, liquids, molded balls and combinations thereof.

7. A composition consisting of:

a therapeutically effective amount of an extract consisting of individual extracts of Radix isatidis, Flos Lonicerae , and Poria cocos (Schw.) Wolf; for the treatment of immunodeficiency related inflammation; and

at least one of a pharmaceutically acceptable carrier and an excipient, wherein the individual extracts of Radix isatidis, Lonicera japonicum and Poria cocos F. A. Wolf are present in a ratio of about 1.0:1.0:2.1.

8. A composition according to claim 7 , wherein said composition is an oral dosage form.

9. A composition according to claim 7 , wherein said composition is an oral dosage form, and wherein said oral dosage form is selected from the group consisting of tablets, pills, softgel capsules, hard capsules, granules, powders, concentrates, syrups, liquids, molded balls and combinations thereof.

10. A composition consisting of:

a therapeutically effective amount of an extract consisting of individual extracts of Radix isatidis, Flos Lonicerae , and Poria cocos (Schw.) Wolf; for the treatment of immune system function; and

at least one of a pharmaceutically acceptable carrier and an excipient, wherein the individual extracts of Radix isatidis, Lonicera japonicum and Poria cocos F. A. Wolf are present in a ratio of about 1.0:1.0:2.1.

11. A composition according to claim 10 , wherein said composition is an oral dosage form.

12. A composition according to claim 10 , wherein said composition is an oral dosage form, and wherein said oral dosage form is selected from the group consisting of tablets, pills, softgel capsules, hard capsules, granules, powders, concentrates, syrups, liquids, molded balls and combinations thereof.

13. A method for producing a composition consisting of a therapeutically effective amount of an extract consisting of individual extracts of Radix isatidis, Flos Lonicerae , and Poria cocos (Schw.) Wolf and at least one of a pharmaceutically acceptable carrier and an excipient, for treating one or more of influenza, inflammation and immune system function, said method comprising the step of:

soaking a plant component in an aqueous solvent at a temperature selected from the range of about 20° C. to about 110° C., thereby producing a herbal extraction mixture;

separating a liquid fraction from the herbal extraction mixture, and filtering said liquid fraction to produce an aqueous herbal filtrate;

de-watering the aqueous herbal filtrate to a syrup-like consistency; and

formulating the composition comprising said de-watered herbal filtrate and an acceptable carrier or excipient therefor, wherein the individual extracts of Radix isatidis, Lonicera japonicum and Poria cocos F. A. Wolf are present in a ratio of about 1.0:1.0:2.1.

14. A method according to claim 13 , wherein said composition is formulated as an oral dosage form selected from the group comprising tablets, pills, softgel capsules, granules, powders, concentrates, syrups, liquids, molded balls and combinations thereof.

15. A method according to claim 13 , wherein the aqueous solvent comprises a mixture of water and at least one organic solvent selected from the group comprising ethanol, methanol, isopropyl alcohol, ethyl acetate, ethyl ether, acetonitrile, methylene chloride, hexane, acetic acid, and combinations thereof.

16. A method according to claim 13 , wherein the aqueous solvent further comprises a mixture of water and at least one of an inorganic acid, an inorganic base, and combinations thereof.

17. A method according to claim 13 , additionally comprising steps for dewatering and processing the aqueous herbal filtrate to produce a dried powder.

18. A method for treating one or more of influenza, inflammation by administering a patient a therapeutically effective amount of the composition of claim 1 .

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 6, 2011
From: XIE, XUEJU; KO, JASON JIANG-CHUNG
To: VIVA PHARMACEUTICAL INC.
Reel/Frame 026394/0417 →
Continuity (2)
Provisional Application 61157049 · Mar 3, 2009
Related Publication 20100226936A1 · Sep 9, 2010